Mettler-Toledo International (NYSE:MTD – Get Free Report) and SiBone (NASDAQ:SIBN – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.
Analyst Ratings
This is a summary of current ratings and recommmendations for Mettler-Toledo International and SiBone, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Mettler-Toledo International | 0 | 5 | 5 | 0 | 2.50 |
| SiBone | 0 | 0 | 3 | 0 | 3.00 |
Mettler-Toledo International presently has a consensus target price of $1,311.11, suggesting a potential upside of 0.64%. SiBone has a consensus target price of $23.67, suggesting a potential upside of 41.97%. Given SiBone’s stronger consensus rating and higher possible upside, analysts clearly believe SiBone is more favorable than Mettler-Toledo International.
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Mettler-Toledo International | $3.87 billion | 6.93 | $863.14 million | $39.49 | 32.99 |
| SiBone | $167.18 million | 4.30 | -$30.91 million | ($0.56) | -29.77 |
Mettler-Toledo International has higher revenue and earnings than SiBone. SiBone is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
Mettler-Toledo International has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500. Comparatively, SiBone has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500.
Profitability
This table compares Mettler-Toledo International and SiBone’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Mettler-Toledo International | 21.46% | -476.07% | 26.05% |
| SiBone | -12.83% | -14.20% | -10.38% |
Institutional and Insider Ownership
95.1% of Mettler-Toledo International shares are held by institutional investors. Comparatively, 98.1% of SiBone shares are held by institutional investors. 1.9% of Mettler-Toledo International shares are held by company insiders. Comparatively, 4.0% of SiBone shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
Mettler-Toledo International beats SiBone on 9 of the 14 factors compared between the two stocks.
About Mettler-Toledo International
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments. Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company’s retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.
About SiBone
SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
